BioSavita | Accelerated Antibody Development

Technology & Licensing

Synthetic bioengineering is the design and construction of new biological systems to serve mankind. It is an emerging area of research that proactively integrates the co-development of biology and engineering. By uniting the power of these two disciplines, unparalleled gains can be made in the speed and efficiency of developing new biological medicines.

Pipeline

We have applied proprietary synthetic bioengineering technologies to the development of our own pipeline of biosimilar for cancer therapeutics. We are also applying yeast technology for cost-effective production of biologicals in biodefense application.

Team

BioSavita’s leadership is comprised of senior executives who have successfully launched and led early stage ventures in multiple biotech and pharmaceutical companies along with world-leading scientists and researchers.

Technology & Licensing

Pipeline

Team

BioSavita is focused on rapidly bringing new antibody medicines to patients in partnership with biopharmaceutical companies.

In The Pipeline

Meet The Team

Latest News

Site Map